[ Price : $8.95]
Federal Register Notice: FDA releases a draft guidance: Liposome Drug Products: CMC; Human Pharmacokinetics and Bioavailability; a...[ Price : $8.95]
A Government Accountability Office analysis of FDA-ordered postmarket surveillance studies between 3/2008 and 2/2015 finds that 94...[ Price : $8.95]
Federal Register Notice: FDA reopens the comment period on a draft guidance: Human Cells, Tissues, and Cellular and Tissue-Based P...[ Price : $8.95]
FDA accepts for filing a Lipocine NDA for LPCN 1021, an oral product candidate for testosterone replacement therapy in adult males...[ Price : $8.95]
Federal Register Notice: FDA releases a draft guidance: Homologous Use of Human Cells, Tissues, and Cellular and Tissue-Based Prod...[ Price : $8.95]
FDA grants Daiichi Sankyo and Plexxikon a breakthrough therapy designation for their investigational oral CSF-1R inhibitor pexidar...[ Price : $8.95]
Federal Register Notice: The Office of Management and Budget approves a collection of information on the impact of ad exposure fre...[ Price : $8.95]
Federal Register Notice: The Office of Management and Budget approves a collection of information on a survey on the physical char...